Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Articolo
Data di Pubblicazione:
2014
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Ok, Cy; Xu Monette, Zy; Tzankov, A; O'Malley, Dp; Montes Moreno, S; Visco, C; Møller, Mb; Dybkaer, K; Orazi, A; Zu, Y; Bhagat, G; Richards, Kl; Hsi, Ed; Han van Krieken, J; Ponzoni, Maurilio; Farnen, Jp; Piris, Ma; Winter, Jn; Medeiros, Lj; Young, Kh
Link alla scheda completa:
Pubblicato in: